EPO

Could erythropoietin protect the brain after out-of-hospital cardiac arrest? This 2016 appraisal examines a French randomised trial that found no neurological or survival advantage and more adverse events, including thromboembolism, highlighting the gap between biological promise and demonstrated patient benefit.